Natera Inc., a global leader in cell-free DNA testing and precision medicine, has announced a collaboration with NVIDIA to accelerate the development of Natera's multimodal AI foundation model platform. The partnership will integrate Natera's extensive longitudinal and multi-time point in vivo datasets with NVIDIA's high-performance computing platforms and AI frameworks. This collaboration aims to establish advanced computational infrastructure for training and deploying large-scale AI models on complex medical datasets, enhancing precision diagnostics, therapeutic insights, and personalized medicine applications.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Natera Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260112000650) on January 12, 2026, and is solely responsible for the information contained therein.
Comments